Live Breaking News & Updates on National Sales Perspectives|Page 3

Stay updated with breaking news from National sales perspectives. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Drugs With Low Clinical Benefit Have Higher Direct-to-Consumer Spending

Among the top-selling US drugs, those with lower added clinical benefit ratings and higher total drug sales have higher manufacturer spending on direct-to-consumer advertising. ....

United States , National Sales Perspectives , Journal Of The American Medical Association , Healthday News , American Medical , Sales Perspectives ,

Drugs With Low Clinical Benefit Show Higher Direct-to-Consumer Spending

WEDNESDAY Feb. 15, 2023 (HealthDay News) Among the top-selling U.S. drugs, those with lower added clinical benefit ratings and higher total drug sales have higher manufacturer spending on direct-to-consumer ....

United States , Michaelj Distefano , Johns Hopkins University In Baltimore , National Sales Perspectives , Journal Of The American Medical Association , Healthday News , American Medical , Johns Hopkins University , Sales Perspectives , Physicians Briefing ,

Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising

This pharmacoeconomic study estimates associations between drug characteristics and the proportion of manufacturer promotional spending allocated to direct-to-c ....

Merative Marketscan Research Databases , World Health Organization , Drug Administration , National Sales Perspectives , Sales Perspectives , Haute Autorit , Patented Medicine Prices Review Board , Medicare Spending ,

NaxSwab™ OTC novel naloxone nasal swab demonstrates faster absorption and higher early exposures against other naloxone products in clinical study

/PRNewswire/ Pocket Naloxone Corp., a startup pharmaceutical company with the vision of enhancing naloxone delivery, today announced positive results from. ....

United States , Ashanthi Mathai , Andrea Barthwell , Kathleen Van Gorden , American Society For Addiction Medicine , Prnewswire Pocket Naloxone Corp , Drug Administration , Naloxone Corp , National Sales Perspectives , Pocket Naloxone , Board Liaison , American Society , Addiction Medicine , Deputy Director , Demand Reduction , White House Office , National Drug Control , Federal Register , Certain Naloxone Hydrochloride Drug Products , Nonprescription Use , Sales Perspectives , Pocket Naloxone Corp ,

NaxSwab™ OTC novel naloxone nasal swab demonstrates faster absorption and higher early exposures against other naloxone products in clinical study

NaxSwab™ OTC novel naloxone nasal swab demonstrates faster absorption and higher early exposures against other naloxone products in clinical study
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Ashanthi Mathai , Andrea Barthwell , Kathleen Van Gorden , American Society For Addiction Medicine , Prnewswire Pocket Naloxone Corp , Drug Administration , Naloxone Corp , National Sales Perspectives , Pocket Naloxone , Board Liaison , American Society , Addiction Medicine , Deputy Director , Demand Reduction , White House Office , National Drug Control , Federal Register , Certain Naloxone Hydrochloride Drug Products , Nonprescription Use , Sales Perspectives , About Pocket Naloxone ,